Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?

2010 ◽  
Vol 87 (4) ◽  
pp. 396-398 ◽  
Author(s):  
M A Febbraio ◽  
S Rose-John ◽  
B K Pedersen
Keyword(s):  
Interleukin 6 ◽  
Inflammatory Diseases ◽  
Receptor Blockade ◽  
Holy Grail ◽  
Interleukin 6 Receptor

The role of soluble interleukin-6 receptor in inflammatory diseases

2005 ◽  
Vol 98 (1) ◽  
pp. 171
Author(s):  
Marcello Maggio ◽  
Shehzad Basaria ◽  
Gian Paolo Ceda ◽  
Graziano Ceresini ◽  
Giorgio Valenti ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Inflammatory Diseases ◽  
Interleukin 6 Receptor

scholarly journals Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study

2020 ◽  
pp. annrheumdis-2020-218243 ◽  
Author(s):  
Nicola Potere ◽  
Marcello Di Nisio ◽  
Donatella Cibelli ◽  
Rosa Scurti ◽  
Antonella Frattari ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Case Control Study ◽  
Case Control ◽  
Receptor Blockade ◽  
Interleukin 6 Receptor ◽  
Control Study

scholarly journals Functional and Morphological Improvement of Dystrophic Muscle by Interleukin 6 Receptor Blockade

EBioMedicine ◽  
2015 ◽  
Vol 2 (4) ◽  
pp. 285-293 ◽  
Author(s):  
Laura Pelosi ◽  
Maria Grazia Berardinelli ◽  
Loredana De Pasquale ◽  
Carmine Nicoletti ◽  
Adele D'Amico ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Receptor Blockade ◽  
Dystrophic Muscle ◽  
Interleukin 6 Receptor
Sign in / Sign up

Export Citation Format

Share Document